Packet identity

Packet ID
opportunities:opp-argonne-cri-cohort-2027
Packet SHA-256 identity
089fd5a03a3749955a999f882e4cc10c33dc723316fb7897b549acf5a2bbcdbd
Corpus SHA-256 identity
8fa944604ca189f5a9216ca59f640ad2ca20972ad512f2f4970764716782e18d
Release ID
public-alpha-2026-07-26-research-visuals-r14
Source commit
3eb036fce3d711336c8c605625895e8a2e799ab0
Frozen corpus date
2026-07-25
Primary records
1
Reference sources
1

Questions and exclusions

Required questions

  1. Required question 1 (exact ID: question-1)
    Does the official source support the opportunity identity, status, timing, eligibility, and access constraints?
  2. Required question 2 (exact ID: question-2)
    Is the proposed fit specific and proportionate without implying availability, invitation, selection, or funding?
  3. Required question 3 (exact ID: question-3)
    What deadline, rule, jurisdiction, cost, conflict, or accessibility fact would change the proposed next action?

Explicit exclusions

  • Review does not submit, register, apply, contact, commit, purchase, or establish eligibility.
  • Provider prestige and apparent fit cannot replace current official terms.

Requested controlled scopes: ecosystem-due-diligence, opportunity-eligibility-access

Frozen-evidence decision window: 30 days from the packet freeze. Not applicable to this packet family.

Complete primary record set

Every record below has one primary packet owner. Decisions must bind to the exact record and packet fingerprints; a changed lesson body, evidence grade, citation, locator, source snapshot, requirement, policy, release, or commit expires the old packet.

  1. opportunity · opp-argonne-cri-cohort-2027

    Argonne Chain Reaction Innovations — Cohort 2027

    Record fingerprint
    f2efe90c8f828db0e1e4bd35243b8365d2dca91cf5c438549bce9aa88f1f470e
    Minimum approvals
    1
    Required scope groups
    bounded-competence: ecosystem-due-diligence, opportunity-eligibility-access
    High-consequence domains
    None under the named two-person rule
    Review state
    pending
    Published human decisions
    0
    Inspect the complete frozen review surface
    ID
    opp-argonne-cri-cohort-2027
    Name
    Argonne Chain Reaction Innovations — Cohort 2027
    Provider
    Argonne National Laboratory Chain Reaction Innovations
    Kind
    Laboratory-embedded entrepreneurship program
    Timing
    The Cohort 2027 application is scheduled to open September 15 and close October 30, 2026 at 5 p.m. on the official page. The current page still labels the application closed because the 2026 cohort window has ended.
    Fit
    Advanced materials, industrial efficiency, manufacturing digitization, advanced manufacturing, energy-water systems, computing, semiconductors, grids, storage, critical materials, recycling, buildings, scientific platforms, transport efficiency, and energy technology
    Status
    forthcoming application window; not yet open
    Verified At
    2026-07-26
    Current Until
    2026-08-02
    Eligibility
    The official page says preferred applicants are technical founders with hands-on laboratory experience developing an early-stage innovation and that applicants must be U.S. citizens or lawful permanent residents when applying. Four yes-or-no eligibility questions, the forthcoming 2027 application, online portal, FAQ, appointment, laboratory, intellectual-property, safety, conflict, and program rules control actual eligibility.
    Access Notes
    CRI states that the two-year program includes a $115,000 annual stipend plus healthcare benefits, non-dilutive support, Argonne facilities and expertise, and business networks, and that Argonne and DOE take no startup equity. Those statements do not establish acceptance, total project funding, laboratory or equipment availability, intellectual-property terms, outside-work permissions, safety approval, incorporation needs, relocation, accessibility, or fit for a GShips product.
    Founder Action
    Before the window opens, prepare only a no-application fit memo for a genuinely laboratory-dependent Earth-first technology, comparing CRI with non-laboratory and non-venture alternatives. Do not pre-apply, nominate, contact staff, incorporate, disclose confidential material, or imply Argonne or DOE support without separate authorization and independent eligibility, technical, intellectual-property, safety, conflict, budget, and civil-and-defensive review.
    Evidence Boundary
    Argonne's official application page supports the September 15–October 30, 2026 Cohort 2027 window, 5 p.m. close statement, U.S.-citizen or lawful-permanent-resident rule, preferred technical-founder profile, two-year duration, $115,000 annual stipend plus healthcare, stated non-dilutive support, no-equity statement, and listed priority areas. It does not establish application availability before September 15, a specific person's eligibility, acceptance, adequate funding, facility access, intellectual-property outcome, safety approval, accessibility, relocation, startup success, or relationship.
    Relationship
    indexed only; no formal relationship
    Action Status
    proposed; not undertaken
    Conflicts
    Potential stipend, benefits, laboratory access, investor and corporate networks, public-laboratory reputation, technology and intellectual-property interests, relocation, selection, and the publisher's intended venture require independent review.
    What Would Change
    Publication of the Cohort 2027 application and eligibility questions, an opening or deadline change, updated stipend or benefit terms, an independent fit memo, or changed intellectual-property, safety, laboratory, conflict, appointment, access, or applicant rules would change this assessment.
Equivalent record table for this packet
RecordSubjectFingerprintApprovalsScope groups
opportunity:opp-argonne-cri-cohort-2027 Argonne Chain Reaction Innovations — Cohort 2027 f2efe90c8f828db0e1e4bd35243b8365d2dca91cf5c438549bce9aa88f1f470e 1 bounded-competence: ecosystem-due-diligence, opportunity-eligibility-access

Frozen source snapshots

Source inclusion does not determine the disposition. Reviewers must inspect the cited locator and relation, note inaccessible material, and identify stronger or conflicting evidence.

Sources, verification dates, scope notes, and exact fingerprints
Source IDSourceCheckedScope boundaryFingerprint
official-opportunity-opp-argonne-cri-cohort-2027 Argonne Chain Reaction Innovations — Cohort 2027 (opens external site in a new tab) 2026-07-26 Argonne's official application page supports the September 15–October 30, 2026 Cohort 2027 window, 5 p.m. close statement, U.S.-citizen or lawful-permanent-resident rule, preferred technical-founder profile, two-year duration, $115,000 annual stipend plus healthcare, stated non-dilutive support, no-equity statement, and listed priority areas. It does not establish application availability before September 15, a specific person's eligibility, acceptance, adequate funding, facility access, intellectual-property outcome, safety approval, accessibility, relocation, startup success, or relationship. 2cbef36760746426a53a95f5713574dbaf04f5382fc4dcdd2270260078f55278

Offline packet and worksheet

Downloads contain no reviewer contact details. Downloading does not create an account or store a review response in the GShips application. Ordinary provider request or analytics logs may record the download request. Work locally: the public site has no review account, upload endpoint, or decision-submission API.

Frozen packet · JSON

15.6 KB · packet identity 089fd5a03a374995…

Download packet

Blank decision worksheet · JSON

3.0 KB · template identity 2e9b4eaa6fe91f3e…

Download blank JSON

Review-notes worksheet · Markdown

Readable notes companion only—not a decision-bundle equivalent. Use the closed JSON template for structural validation.

Download notes worksheet

Do not paste a completed decision, identity documents, private contact data, confidential conflict evidence, medical information, controlled material, or exploit details into a public form. Until a separately authorized private handoff exists, retain the completed worksheet locally.

Packet schema · JSON · Decision-bundle schema · JSON

Validate offline

Use Node.js 22.13.0 or later. Keep the packet, worksheet, completed decision, and all six kit files together in a local directory.

  1. Download the six kit files below. Complete a copy of the JSON template offline and preserve its templateFingerprint.
  2. Finalize a separate output file.
    node finalize-review-decision.mjs \
      --input DRAFT.json \
      --output COMPLETED.json

    This marks the copy complete and calculates an unkeyed canonical bundle fingerprint. A fingerprint detects changes; it is not a reviewer signature.

  3. Validate the packet and completed copy.
    node check-review-decisions.mjs \
      --packet PACKET.json \
      --decision COMPLETED.json

    Add another --decision for each independent reviewer.

  4. Interpret the result narrowly. A zero exit proves structural consistency only. Neither command appoints or qualifies a reviewer, establishes independence, accepts a decision, or authorizes publication.

Completion criteria

Every primary record must receive the required number of valid, current-fingerprint approvals; every complementary scope group and required domain must be covered; any unresolved revise, contest, or reject disposition blocks publication.

Named medical, reproductive, nuclear, radiation, cybersecurity, governance, and dual-use conclusions require two distinct qualified independent humans covering complementary domain-method and rights/public-interest scopes.

  • Reviewer identity, qualification, independence, conflicts, and compensation must be assessed by accountable human governance; local validation can only report structural validity.
  • Approve, revise, contest, reject, and recuse remain visible. A negative finding cannot be hidden by an aggregate approval percentage.
  • Revision creates a new record and packet fingerprint. Prior approvals do not carry forward automatically.
  • AI may assist with clerical comparison but cannot count as an independent reviewer, identity attestor, appeal authority, or second person.

Prepared review packet · 0 published human decisions · Independent review pending · Suggest a correction

Accountability record

How to inspect this page

Scope: Prepared review packet opportunities:opp-argonne-cri-cohort-2027 · 089fd5a03a3749955a999f882e4cc10c33dc723316fb7897b549acf5a2bbcdbd

Page citations and accountability links

  • Exact frozen packet
    Complete packet payload; SHA-256 089fd5a03a3749955a999f882e4cc10c33dc723316fb7897b549acf5a2bbcdbd · fingerprint-bound review artifact
  • Blank closed decision template
    Offline structured-decision starting point · unsubmitted local artifact
  • Review-notes worksheet
    Human-readable notes companion; not validator input · offline notes aid
  • Review corpus index
    Corpus SHA-256 8fa944604ca189f5a9216ca59f640ad2ca20972ad512f2f4970764716782e18d · release and ownership index

Assumptions and limits

  • The exact packet, record, source, policy, release, and source-commit fingerprints bound this prepared page; human review has not started.
  • Downloading, local structural validation, or completing notes does not appoint or qualify a reviewer, establish independence, accept a decision, authorize publication, or create a relationship.

What would change this page?

Staffed governance, appointed qualified reviewers, completed record-level decisions, published conflicts, minority findings, corrections, or changed review policy would change this page.

People, review, and conflicts

Prepared by
GShips Project
Editorial status
public-alpha accountability pass
Editorial reviewer
GShips Project AI-assisted editorial synthesis
Last editorial review
2026-07-26
Independent review
pending
Independent reviewer
No independent reviewer assigned
Last independent review
No independent-review date exists
Last content edit
2026-07-25

Declared conflicts

  • The maintainer intends to explore a commercial venture based on some GShips work. No entity, outside funding, customer, sponsor, or indexed-organization relationship currently exists.

Suggest a correction to this page